Ardelyx, Inc. (ARDX)
3.575
-0.04
(-1.24%)
USD |
NASDAQ |
Sep 11, 16:00
3.575
0.00 (0.00%)
After-Hours: 16:29
Ardelyx Gross Profit (TTM) : 422.15M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 422.15M |
| March 31, 2026 | 392.26M |
| December 31, 2025 | 364.72M |
| September 30, 2025 | 348.63M |
| June 30, 2025 | 325.16M |
| March 31, 2025 | 303.74M |
| December 31, 2024 | 281.00M |
| September 30, 2024 | 212.57M |
| June 30, 2024 | 178.14M |
| March 31, 2024 | 132.21M |
| December 31, 2023 | 103.58M |
| September 30, 2023 | 114.68M |
| June 30, 2023 | 69.89M |
| March 31, 2023 | 53.97M |
| December 31, 2022 | 43.44M |
| September 30, 2022 | 3.42M |
| June 30, 2022 | 0.666M |
| March 31, 2022 | -0.691M |
| December 31, 2021 | 4.553M |
| September 30, 2021 | 5.354M |
| June 30, 2021 | 5.354M |
| March 31, 2021 | 6.058M |
| December 31, 2020 | 1.505M |
| September 30, 2020 | 0.704M |
| June 30, 2020 | 2.477M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.773M |
| December 31, 2019 | 1.098M |
| September 30, 2019 | 0.51M |
| June 30, 2019 | -1.755M |
| March 31, 2019 | -2.394M |
| December 31, 2018 | -0.20M |
| September 30, 2018 | 33.99M |
| June 30, 2018 | 33.76M |
| March 31, 2018 | 33.75M |
| December 31, 2017 | 31.64M |
| September 30, 2017 | -2.356M |
| June 30, 2017 | -1.906M |
| March 31, 2017 | -1.579M |
| December 31, 2016 | -1.295M |
| September 30, 2016 | -1.193M |
| June 30, 2016 | -1.182M |
| March 31, 2016 | 17.12M |
| December 31, 2015 | 23.20M |
| September 30, 2015 | 23.49M |
| June 30, 2015 | 23.75M |
| March 31, 2015 | 5.764M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| REGENXBIO, Inc. | 135.34M |
| ACADIA Pharmaceuticals, Inc. | 1.038B |
| Alnylam Pharmaceuticals, Inc. | 3.827B |
| Anika Therapeutics, Inc. | 75.00M |
| Savara, Inc. | -0.281M |